Skip to Content

PT Enseval Putera Megatrading Tbk FEK

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FEK is trading at a 123% premium.
Price
€0.12
Fair Value
€5.13
Uncertainty
Very High
1-Star Price
€9.51
5-Star Price
€2.36
Economic Moat
Lyqvl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FEK is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
7.35
Price/Sales
0.23
Dividend Yield (Trailing)
4.75%
Dividend Yield (Forward)
< 0.01%
Total Yield
4.75%

Company Profile

PT Enseval Putera Megatrading Tbk is a general distributor dealing in pharmaceutical products, consumer products, and medical devices. It also acts as an agent and distributor of chemical raw materials for the pharmaceutical, cosmetics, and food industries. The company's business segments are; Pharmaceuticals which generates key revenue, Consumer products, and others.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Value
Total Number of Employees
5,115

Comparables

Valuation

Metric
FEK
TSPC
DEPO
Price/Earnings (Normalized)
7.359.2229.81
Price/Book Value
0.791.162.06
Price/Sales
0.230.700.95
Price/Cash Flow
7.226.2027.51
Price/Earnings
FEK
TSPC
DEPO

Financial Strength

Metric
FEK
TSPC
DEPO
Quick Ratio
1.412.010.50
Current Ratio
2.602.751.79
Interest Coverage
61.2417.7613.41
Quick Ratio
FEK
TSPC
DEPO

Profitability

Metric
FEK
TSPC
DEPO
Return on Assets (Normalized)
6.42%9.85%4.62%
Return on Equity (Normalized)
9.68%14.61%7.12%
Return on Invested Capital (Normalized)
9.52%11.54%6.15%
Return on Assets
FEK
TSPC
DEPO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpLzyycngKtygmgq$72.2 Bil
COR
Cencora IncCtyxtqflGcwkkx$44.2 Bil
CAH
Cardinal Health IncRfqkskrqKtvnhk$24.0 Bil
SHTDY
Sinopharm Group Co Ltd ADRNwxzd$8.9 Bil
SHTDF
Sinopharm Group Co LtdMmvyn$8.9 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HYtlpblk$8.6 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HBsmtdy$8.6 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoKmtgr$8.4 Bil
MAHLY
Medipal Holdings Corp ADRRymhz$3.1 Bil
MEPDF
Medipal Holdings CorpQqf$3.1 Bil

Sponsor Center